 Pfizer inked a 5.4 billion deal Monday to buy Global Blood Therapeutics, confirming rumors that sent GBT stock skyrocketing last week. The post Pfizer Inks 5.4 Billion Deal To Acquire Global Blood Therapeutics appeared first on Investors Business Daily. 